Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

July 31, 2016

Conditions

DiabetesAtherosclerosis

Interventions

DRUG

sitagliptin

100 mg pill, administered once/day orally

DRUG

Placebo

Matching placebo in appearance given once/day orally

Trial Locations (1)

Medical College of Wisconsin, Milwaukee

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Medical College of Wisconsin

OTHER

NCT01859793 - Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy | Biotech Hunter | Biotech Hunter